These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23498286)

  • 1. Cardiomyocyte apoptosis in the failing heart--a critical review from definition and classification of cell death.
    Takemura G; Kanoh M; Minatoguchi S; Fujiwara H
    Int J Cardiol; 2013 Sep; 167(6):2373-86. PubMed ID: 23498286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of apoptosis in remodeling after myocardial infarction.
    Takemura G; Fujiwara H
    Pharmacol Ther; 2004 Oct; 104(1):1-16. PubMed ID: 15500905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological aspects of apoptosis in heart diseases.
    Takemura G; Fujiwara H
    J Cell Mol Med; 2006; 10(1):56-75. PubMed ID: 16563222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed cell death in the progression of heart failure.
    Sabbah HN; Sharov VG; Goldstein S
    Ann Med; 1998 Aug; 30 Suppl 1():33-8. PubMed ID: 9800881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell death, tissue hypoxia and the progression of heart failure.
    Sabbah HN; Sharov VG; Goldstein S
    Heart Fail Rev; 2000 Jun; 5(2):131-8. PubMed ID: 16228140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of apoptosis using in situ markers for DNA strand breaks in the failing human heart. Fact or epiphenomenon?
    Hughes SE
    J Pathol; 2003 Oct; 201(2):181-6. PubMed ID: 14517834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytopathological basis of heart failure--cardiomyocyte apoptosis, interstitial fibrosis and inflammatory cell response.
    Petrovic D
    Folia Biol (Praha); 2004; 50(2):58-62. PubMed ID: 15222127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for caspase-1 in heart failure.
    Merkle S; Frantz S; Schön MP; Bauersachs J; Buitrago M; Frost RJ; Schmitteckert EM; Lohse MJ; Engelhardt S
    Circ Res; 2007 Mar; 100(5):645-53. PubMed ID: 17303764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phenotype alterations of failing myocardium].
    Takemura G; Fujiwara H
    Nihon Rinsho; 2003 May; 61(5):731-8. PubMed ID: 12754995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte death and renewal in the normal and diseased heart.
    Buja LM; Vela D
    Cardiovasc Pathol; 2008; 17(6):349-74. PubMed ID: 18402842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy in transition from hypertrophic cardiomyopathy to heart failure.
    Fidziańska A; Bilińska ZT; Walczak E; Witkowski A; Chojnowska L
    J Electron Microsc (Tokyo); 2010; 59(2):181-3. PubMed ID: 19797323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
    Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
    Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocyte death and the ageing and failing heart.
    Goldspink DF; Burniston JG; Tan LB
    Exp Physiol; 2003 May; 88(3):447-58. PubMed ID: 12719770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic cardiomyocyte death in fatal myocarditis.
    Kytö V; Saraste A; Saukko P; Henn V; Pulkki K; Vuorinen T; Voipio-Pulkki LM
    Am J Cardiol; 2004 Sep; 94(6):746-50. PubMed ID: 15374778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting survival signaling in heart failure.
    Morissette MR; Rosenzweig A
    Curr Opin Pharmacol; 2005 Apr; 5(2):165-70. PubMed ID: 15780826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis and heart failure: mechanisms and therapeutic implications.
    Chen QM; Tu VC
    Am J Cardiovasc Drugs; 2002; 2(1):43-57. PubMed ID: 14727998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in hypertensive heart disease: a clinical approach.
    González A; Ravassa S; López B; Loperena I; Querejeta R; Díez J
    Curr Opin Cardiol; 2006 Jul; 21(4):288-94. PubMed ID: 16755196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in both death and survival signals for apoptosis in heart failure due to volume overload.
    Dent MR; Das S; Dhalla NS
    J Mol Cell Cardiol; 2007 Dec; 43(6):726-32. PubMed ID: 17931652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin determines cardiac function by controlling total cardiomyocyte number.
    Levkau B; Schäfers M; Wohlschlaeger J; von Wnuck Lipinski K; Keul P; Hermann S; Kawaguchi N; Kirchhof P; Fabritz L; Stypmann J; Stegger L; Flögel U; Schrader J; Fischer JW; Hsieh P; Ou YL; Mehrhof F; Tiemann K; Ghanem A; Matus M; Neumann J; Heusch G; Schmid KW; Conway EM; Baba HA
    Circulation; 2008 Mar; 117(12):1583-93. PubMed ID: 18332262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cardiomyocyte survival-apoptosis balance in hypertensive cardiac remodeling.
    Fortuño MA; López N; González A; Díez J
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):293-307. PubMed ID: 15030288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.